Correlation Between IShares Genomics and Amplify Seymour
Can any of the company-specific risk be diversified away by investing in both IShares Genomics and Amplify Seymour at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Genomics and Amplify Seymour into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Genomics Immunology and Amplify Seymour Cannabis, you can compare the effects of market volatilities on IShares Genomics and Amplify Seymour and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Genomics with a short position of Amplify Seymour. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Genomics and Amplify Seymour.
Diversification Opportunities for IShares Genomics and Amplify Seymour
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between IShares and Amplify is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding iShares Genomics Immunology and Amplify Seymour Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amplify Seymour Cannabis and IShares Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Genomics Immunology are associated (or correlated) with Amplify Seymour. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amplify Seymour Cannabis has no effect on the direction of IShares Genomics i.e., IShares Genomics and Amplify Seymour go up and down completely randomly.
Pair Corralation between IShares Genomics and Amplify Seymour
Given the investment horizon of 90 days iShares Genomics Immunology is expected to generate 0.25 times more return on investment than Amplify Seymour. However, iShares Genomics Immunology is 4.0 times less risky than Amplify Seymour. It trades about -0.08 of its potential returns per unit of risk. Amplify Seymour Cannabis is currently generating about -0.25 per unit of risk. If you would invest 2,400 in iShares Genomics Immunology on August 24, 2024 and sell it today you would lose (70.00) from holding iShares Genomics Immunology or give up 2.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
iShares Genomics Immunology vs. Amplify Seymour Cannabis
Performance |
| Timeline |
| iShares Genomics Imm |
| Amplify Seymour Cannabis |
IShares Genomics and Amplify Seymour Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IShares Genomics and Amplify Seymour
The main advantage of trading using opposite IShares Genomics and Amplify Seymour positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Genomics position performs unexpectedly, Amplify Seymour can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amplify Seymour will offset losses from the drop in Amplify Seymour's long position.| IShares Genomics vs. Global X Clean | IShares Genomics vs. Global X Renewable | IShares Genomics vs. Global X Thematic | IShares Genomics vs. Global X AgTech |
| Amplify Seymour vs. SPDR Kensho New | Amplify Seymour vs. Global X FinTech | Amplify Seymour vs. iShares Genomics Immunology | Amplify Seymour vs. Aquagold International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |